Baidu
map
AUDIOL NEURO-OTOL 润色咨询

Audiology And Neurotology

出版年份:1996 年文章数:1509 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0<br>经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... <br> Submitted: 08/11/2016 Current Status: Under Review 四个月了 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) <br> 201611004 Revision 0 The effect ... <br> Submitted: 08/11/2016 Current Status: Under Review <br> 已经三个多月了,发信问也不回,该如何是好????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    引言和讨论如何写的不重复?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0<br>经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... <br> Submitted: 08/11/2016 Current Status: Under Review 四个月了 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) <br> 201611004 Revision 0 The effect ... <br> Submitted: 08/11/2016 Current Status: Under Review <br> 已经三个多月了,发信问也不回,该如何是好????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    怎么撰写引言?区别于讨论?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0<br>经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... <br> Submitted: 08/11/2016 Current Status: Under Review 四个月了 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) <br> 201611004 Revision 0 The effect ... <br> Submitted: 08/11/2016 Current Status: Under Review <br> 已经三个多月了,发信问也不回,该如何是好????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2018-11-08 ms4097232105300978

    审稿速度:4.0
    经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0<br>经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... <br> Submitted: 08/11/2016 Current Status: Under Review 四个月了 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) <br> 201611004 Revision 0 The effect ... <br> Submitted: 08/11/2016 Current Status: Under Review <br> 已经三个多月了,发信问也不回,该如何是好????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2017-03-12 sanming1978

    201611004 Revision 0 The effect of ...
    Submitted: 08/11/2016 Current Status: Under Review 四个月了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1087580, encodeId=a6b5108e58090, content=引言和讨论如何写的不重复?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087579, encodeId=6419108e57910, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848087, encodeId=a1c184808ee3, content=审稿速度:4.0<br>经验分享:每年发文量有点少,可以中的概率有点低,老板非要让我投这个期刊试试,诶 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17a5413995, createdName=ms4097232105300978, createdTime=Thu Nov 08 11:42:02 CST 2018, time=2018-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534123, encodeId=2a435341234d, content=201611004 Revision 0 The effect of ... <br> Submitted: 08/11/2016 Current Status: Under Review 四个月了 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Sun Mar 12 19:20:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532889, encodeId=192653288945, content=Manuscripts Currently Under Consideration (1 manuscript) <br> 201611004 Revision 0 The effect ... <br> Submitted: 08/11/2016 Current Status: Under Review <br> 已经三个多月了,发信问也不回,该如何是好????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677940312, createdName=sanming1978, createdTime=Thu Feb 16 10:38:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2017-02-16 sanming1978

    Manuscripts Currently Under Consideration (1 manuscript)
    201611004 Revision 0 The effect ...
    Submitted: 08/11/2016 Current Status: Under Review
    已经三个多月了,发信问也不回,该如何是好????

    0

共7条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map